Cancer proteomics: The state of the art

Disease Markers

Volumn 17, Issue 2, 2001, Pages 49-57

  Herrmann, Paul C ^a   Liotta, Lance A ^a   Petricoin III, Emanuel F ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Cancer; Laser capture microdissection; Proteomics; Signal transduction

Indexed keywords

CELL PROTEIN; PROTEOME;

ARTICLE; CANCER; CELL ACTIVITY; DISEASE MARKER; EARLY DIAGNOSIS; GENETIC CODE; IMAGE ANALYSIS; INDIVIDUALIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN INTERACTION;

EID: 0034798922     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2001/327047     Document Type: Article

References (51)

1. The sequence of the human genome
2. A physical map of the human genome
3. Cancer proteomics: From identification of novel markers to creation of artificial learning models for tumor classification
4. A network of protein-protein interactions in yeast
5. Proteomics: The post-genome revolution
6. Molecular analysis of commensal host-microbial relations hips in the intestine
7. Proteomics - A new way for drug target discovery
8. Analysis of polypeptide expression in benign and malignant human breast lesions
9. Relationship between TA01 and TA02 polypeptides associated with lung adenocarcinoma and histocytological features
10. Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma
11. Identification of novel MAP kinase pathway signaling targets by functional proteomics and mass spectrometry
12. Tailored therapy for aggressive non-Hodgkin's lymphoma: Results of a phase II study with a long-term follow-up
13. Tailored therapy to fit individual profiles - Genetics and coronary artery disease
14. In search of perverse polymorphisms
15. Molecular profiling of human cancer
16. Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines
17. Laser capture microdissection
18. Laser capture microdissection: Molecular analysis of tissue
19. Ablation of polymers and biological tissue by ultraviolet-lasers
20. Tissue microarrays for high-throughput molecular profiling of tumor specimens
21. The current state of two-dimensional electrophoresis with immobilized pH gradients
22. Keratin expression and its significance in five cultured melanoma cell lines derived from primary, recurrent and metastasized melanomas
23. Identification of keratins 18, 19 and heat-shock protein 90 beta as candidate substrates of proteolysis during ionizing radiation-induced apoptosis of estrogen-receptor negative breast tumor cells
24. Differential expression of stathmin during neoplastic conversion of human prostate epithelial cells is reversed by hypomethylating agent, 5-azacytidine
25. Effect of glucocorticoid hormone on nuclear matrix in cervical cancer cells in vitro
26. Bladder squamous cell carcinoma biomarkers derived from proteomics
27. Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties
28. Two-dimensional electrophoretic study of normal colon mucosa and colorectal cancer
29. Quantitative protein changes in metastatic versus primary epithelial ovarian carcinoma
30. Characterization of gene expression in clinical lung cancer materials by two-dimensional polyacrylamide gel electrophoresis
31. Renal cell carcinoma and normal kidney protein expression
32. Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas
33. Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas
34. A two-dimensional electrophoresis database of human breast epithelial cell proteins
35. A two-dimensional gel database of human colon carcinoma proteins
36. An approach to proteomic analysis of human tumors
37. The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis - Preliminary findings
38. Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium
39. Mass-spectrometry of peptides and proteins
40. Fourier transform mass spectrometry
41. Protein sequencing by tandem mass-spectrometry
42. Peptide and protein identification by matrix-assisted laser desorption ionization (MALDI) and MALDI-post-source decay time-of-flight mass spectrometry
43. Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip
44. Differential protein profile in the ear-punched tissue of regeneration and non-regeneration strains of mice: A novel approach to explore the candidate genes for soft-tissue regeneration
45. The use of Seldi ProteinChip (TM) arrays to monitor production of Alzheimer's beta-amyloid in transfected cells
46. The protooncogene TCL1 is an Akt kinase coactivator
47. Protein biomarkers discovered in urine from bladder cancer patients by a novel protein biochip SELDI
48. Laser capture microdissection: Beyond functional genomics to proteomics